Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew H Beck

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
American Journal of Clinical Pathology|April 20, 2011
The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrowSheren F Younes, Andrew H Beck, Robert S Ohgami, et al.
Breast Cancer Research : BCR|August 27, 2013
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtypeMarco M Hefti, Rong Hu, Nicholas W Knoblauch, et al.
The American Journal of Surgical Pathology|January 26, 2011
Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative diseaseRish K Pai, Andrew H Beck, Jonathan Mitchem, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 18, 2015
Image-guided Coring for Large-scale Studies in Molecular PathologyLaleh Montaser-Kouhsari, Nicholas W Knoblauch, Eun-Yeong Oh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 3, 2017
Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor StatusElizabeth E Devore, Erica T Warner, A Heather Eliassen, et al.
Cancer Discovery|March 18, 2014
A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivityBrian C Grabiner, Valentina Nardi, Kıvanc Birsoy, et al.
Breast Cancer Research and Treatment|February 14, 2016
Healthy dietary patterns and risk of breast cancer by molecular subtypeKelly A Hirko, Walter C Willett, Susan E Hankinson, et al.
American Journal of Clinical Pathology|August 19, 2009
Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasiaYasodha Natkunam, Sara Tedoldi, Jennifer C Paterson, et al.
Cell Reports|August 2, 2016
Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived XenograftsMichael Ngo, Arum Han, Anita Lakatos, et al.
Nature|November 29, 2013
Inconsistency in large pharmacogenomic studiesBenjamin Haibe-Kains, Nehme El-Hachem, Nicolai Juul Birkbak, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
American Journal of Clinical Pathology|April 20, 2011
The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrowSheren F Younes, Andrew H Beck, Robert S Ohgami, et al.
Breast Cancer Research : BCR|August 27, 2013
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtypeMarco M Hefti, Rong Hu, Nicholas W Knoblauch, et al.
The American Journal of Surgical Pathology|January 26, 2011
Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative diseaseRish K Pai, Andrew H Beck, Jonathan Mitchem, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 18, 2015
Image-guided Coring for Large-scale Studies in Molecular PathologyLaleh Montaser-Kouhsari, Nicholas W Knoblauch, Eun-Yeong Oh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 3, 2017
Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor StatusElizabeth E Devore, Erica T Warner, A Heather Eliassen, et al.
Cancer Discovery|March 18, 2014
A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivityBrian C Grabiner, Valentina Nardi, Kıvanc Birsoy, et al.
Breast Cancer Research and Treatment|February 14, 2016
Healthy dietary patterns and risk of breast cancer by molecular subtypeKelly A Hirko, Walter C Willett, Susan E Hankinson, et al.
American Journal of Clinical Pathology|August 19, 2009
Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasiaYasodha Natkunam, Sara Tedoldi, Jennifer C Paterson, et al.
Cell Reports|August 2, 2016
Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived XenograftsMichael Ngo, Arum Han, Anita Lakatos, et al.
Nature|November 29, 2013
Inconsistency in large pharmacogenomic studiesBenjamin Haibe-Kains, Nehme El-Hachem, Nicolai Juul Birkbak, et al.
Pageof 14